These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31003494)

  • 1. Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution.
    Larenkov A; Bubenschikov V; Makichyan A; Zhukova M; Krasnoperova A; Kodina G
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31003494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of zirconium-89 solution formulation on the efficiency of [
    Bubenshchikov V; Makichyan A; Larenkov A
    J Labelled Comp Radiopharm; 2022 Nov; 65(13):326-337. PubMed ID: 36138551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a chloride-based
    Graves SA; Kutyreff C; Barrett KE; Hernandez R; Ellison PA; Happel S; Aluicio-Sarduy E; Barnhart TE; Nickles RJ; Engle JW
    Nucl Med Biol; 2018; 64-65():1-7. PubMed ID: 30015090
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pandya DN; Bhatt NB; Almaguel F; Rideout-Danner S; Gage HD; Solingapuram Sai KK; Wadas TJ
    J Nucl Med; 2019 May; 60(5):696-701. PubMed ID: 30442753
    [No Abstract]   [Full Text] [Related]  

  • 5. Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.
    Salih AK; Raheem SJ; Garcia MD; Ahiahonu WK; Price EW
    Inorg Chem; 2022 Dec; 61(51):20964-20976. PubMed ID: 36516446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully Automated
    Poot AJ; Adamzek KWA; Windhorst AD; Vosjan MJWD; Kropf S; Wester HJ; van Dongen GAMS; Vugts DJ
    J Nucl Med; 2019 May; 60(5):691-695. PubMed ID: 30530830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
    Zhai C; He S; Ye Y; Rangger C; Kaeopookum P; Summer D; Haas H; Kremser L; Lindner H; Foster J; Sosabowski J; Decristoforo C
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved production and processing of ⁸⁹Zr using a solution target.
    Pandey MK; Bansal A; Engelbrecht HP; Byrne JF; Packard AB; DeGrado TR
    Nucl Med Biol; 2016 Jan; 43(1):97-100. PubMed ID: 26471714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of
    Imura R; Ida H; Sasaki I; Ishioka NS; Watanabe S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anion exchange and extraction chromatography tandem column isolation of zirconium-89 (
    O'Hara MJ; Carter JC; Kellogg CM; Link JM
    J Chromatogr A; 2022 Aug; 1678():463347. PubMed ID: 35908511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem column isolation of zirconium-89 from cyclotron bombarded yttrium targets using an automated fluidic platform: Anion exchange to hydroxamate resin columns.
    O'Hara MJ; Murray NJ; Carter JC; Kellogg CM; Link JM
    J Chromatogr A; 2018 Sep; 1567():37-46. PubMed ID: 30054129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized methods for the production of high specific-activity zirconium-89.
    Holland JP; Sheh Y; Lewis JS
    Nucl Med Biol; 2009 Oct; 36(7):729-39. PubMed ID: 19720285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-automated production of ⁸⁹Zr-oxalate/⁸⁹Zr-chloride and the potential of ⁸⁹Zr-chloride in radiopharmaceutical compounding.
    Lin M; Mukhopadhyay U; Waligorski GJ; Balatoni JA; González-Lepera C
    Appl Radiat Isot; 2016 Jan; 107():317-322. PubMed ID: 26595775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Desferrichrome Analogues as Versatile
    Adams CJ; Wilson JJ; Boros E
    Mol Pharm; 2017 Aug; 14(8):2831-2842. PubMed ID: 28665620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Brandt M; Cowell J; Aulsebrook ML; Gasser G; Mindt TL
    J Biol Inorg Chem; 2020 Aug; 25(5):789-796. PubMed ID: 32661784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
    Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design.
    Holland JP; Vasdev N
    Dalton Trans; 2014 Jul; 43(26):9872-84. PubMed ID: 24722728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A generic
    Li N; Yu Z; Pham TT; Blower PJ; Yan R
    Int J Nanomedicine; 2017; 12():3281-3294. PubMed ID: 28458546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.